Exclusive video and audio content from CardioSource WorldNews.

ACCEL: Charles Resor, MD
7:33
ACCEL: Charles Resor, MD
ACCEL: Ori Ben-Yahuda, MD
11:10
ACCEL: Ori Ben-Yahuda, MD
ACCEL: L. Kristin Newby, MD, FACC
9:50
ACCEL: L. Kristin Newby, MD, FACC
ACCEL: Win-Kuang Shen, MD
9:00
ACCEL: Win-Kuang Shen, MD
Regenerating Functional Heart Mass and a Comparitive Study in PAD: Updating a Pair of Cover Stories
8:41
Regenerating Functional Heart Mass and a Comparitive Study in PAD: Updating a Pair of Cover Stories
Will Big Data Shine Light at the End of the Tunnel for HDL?
5:41
Will Big Data Shine Light at the End of the Tunnel for HDL?
Many Patients with AF (Really) Don’t Know Their Risk Factors
4:51
Many Patients with AF (Really) Don’t Know Their Risk Factors
Study Suggests it’s Time to Rethink the Design of the Cardiac ICU
6:23
Study Suggests it’s Time to Rethink the Design of the Cardiac ICU
Risk of MACE in Recent PCI Patients Requiring Noncardiac Surgery
5:47
Risk of MACE in Recent PCI Patients Requiring Noncardiac Surgery
Study Raises Important Questions Regarding the 30-day Readmission Metric for HF
6:49
Study Raises Important Questions Regarding the 30-day Readmission Metric for HF
Future of HeART Interventions: PIONEER AF-PCI
5:40
Future of HeART Interventions: PIONEER AF-PCI
ACCEL: C. Michael Gibson, MD
9:59
ACCEL: C. Michael Gibson, MD
ACCEL: Brian Ference, MD
9:35
ACCEL: Brian Ference, MD
ACCEL: Valentine Fuster, MD, PhD, MACC
10:29
ACCEL: Valentine Fuster, MD, PhD, MACC
ACCEL: David Dixon, PharmD
8:33
ACCEL: David Dixon, PharmD
Is the Controversy Over? CV Risk and White Coat Hypertension
14:34
Is the Controversy Over? CV Risk and White Coat Hypertension
Evolut R study: Size Matters and Having Various Sizes Available Matters in TAVR
5:10
Evolut R study: Size Matters and Having Various Sizes Available Matters in TAVR
The YELLOW II IMaging Study
9:57
The YELLOW II IMaging Study
Operator Experience and Volume on Outcomes After Left Main PCI
6:55
Operator Experience and Volume on Outcomes After Left Main PCI
Vorapaxar and Peripheral Revascularization: More Than Purely Anti-Thrombotic Effects?
7:15
Vorapaxar and Peripheral Revascularization: More Than Purely Anti-Thrombotic Effects?
Benchmarking lifestyle modification for Youth Dyslipidemia
6:28
Benchmarking lifestyle modification for Youth Dyslipidemia
The Conundrum of Patients with Chronic Kidney Disease
6:41
The Conundrum of Patients with Chronic Kidney Disease
Percutaneous Mechanical Circulatory Support vs. IABP for Cardiogenic Shock
8:46
Percutaneous Mechanical Circulatory Support vs. IABP for Cardiogenic Shock
First-in-Human Experience with a Novel Temporary Pacing Lead
5:56
First-in-Human Experience with a Novel Temporary Pacing Lead
The Changing Landscape of CVD Trials
9:35
The Changing Landscape of CVD Trials
Outcomes from the RevElution Study
7:03
Outcomes from the RevElution Study
To Operate or Not To Operate After DES: Is It Still A Question?
5:58
To Operate or Not To Operate After DES: Is It Still A Question?
TAVR for Pure Native Aortic Valve Regurgitation: Where are We?
5:57
TAVR for Pure Native Aortic Valve Regurgitation: Where are We?
DAPT Duration After PCI: A Complex Decision or Not?
6:54
DAPT Duration After PCI: A Complex Decision or Not?
Cover Update: 1-year Feasibility Data for a Transcatheter Pulmonary Valve
9:04
Cover Update: 1-year Feasibility Data for a Transcatheter Pulmonary Valve